Author: K-STOCK Editor
[Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P55 (Cosentyx Biosimilar) in the U.S. / 2024-07-01
[Disclosure] Celltrion (068270) – CHMP Positive Opinion Granted for CT-P43 (Stelara Biosimilar) by EMA / 2024-07-01
[Disclosure] Hanwha Ocean (042660) – Other Management Matters (Voluntary Disclosure) (Correction) / 2024-07-01